Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. News
  7. Summary
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement Ending on 29-MAY-2021.

05/29/2021 EDT

Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement Ending on 29-MAY-2021. These Shares will be under lockup for 360 days starting from 3-JUN-2020 to 29-MAY-2021. Details: All founders remain significant shareholders in the Company and have agreed to a lock-up of their shares until year-end 2022 to show their strong commitment for actively supporting the Company going forward, while members of the management team and the Board of Directors of the Company have agreed to a customary 360-day lock up. The Company and other sellers have also agreed to a customary 180-day lock up.


ę S&P Capital IQ 2021
All news about NANOFORM FINLAND OYJ
09/24NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrade
PU
09/24NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
09/23NANOFORM FINLAND OYJ : shortlisted for the European Small and Mid-Cap Awards 2021
AQ
09/09NANOFORM FINLAND OYJ : Herantis Pharma Complete Parkinson's Drug Combo Proof Of Concept
MT
09/09NANOFORM FINLAND OYJ : technology delivers successful results for Herantis CDNF drug candi..
AQ
09/09HERANTIS PHARMA OYJ : Announces Successful rhCDNF Results With Nanoform Technology
AQ
09/09Nanoform technology delivers successful results for Herantis CDNF drug candidate
CI
08/27NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on issue of ..
AQ
08/26NANOFORM FINLAND OYJ : Interim Report for January-June 2021 – Report
PU
08/26NANOFORM FINLAND OYJ : Interim Report January – June 2021
PU
More news
Financials
Sales 2021 2,85 M 3,33 M 3,33 M
Net income 2021 -19,3 M -22,5 M -22,5 M
Net cash 2021 72,2 M 84,3 M 84,3 M
P/E ratio 2021 -28,7x
Yield 2021 -
Capitalization 562 M 658 M 657 M
EV / Sales 2021 172x
EV / Sales 2022 56,1x
Nbr of Employees 106
Free-Float 68,0%
Chart NANOFORM FINLAND OYJ
Duration : Period :
Nanoform Finland Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NANOFORM FINLAND OYJ
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 7,75 €
Average target price 9,15 €
Spread / Average Target 18,1%
EPS Revisions
Managers and Directors
Edward HŠggstr÷m Chief Executive Officer
Albert Hńggstr÷m Chief Financial Officer & Director
Miguel Maria de Oliveira Barreiros Calado Chairman
Niklas Sandler Chief Technology Officer
Gonšalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations
Sector and Competitors
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ9.46%658
JOHNSON & JOHNSON3.68%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY34.09%210 037